If you are in crisis: Samaritans 116 123 (free, 24/7), text SHOUT to 85258, NHS 111, or attend your nearest A&E.
Side effects Finasteride
Finasteride sexual side effects: how common are they?
Short answer
In the three 12-month trials behind the UK product information, drug-related sexual side effects were reported by 3.8% of men on finasteride 1 mg and 2.1% on placebo. Other sources give different bands, because studies define and count them differently. Most men do not report them, and the product information says they resolved in men who stopped and in many who continued. The MHRA warns they may persist after stopping in some.
Key facts
- UK SmPC, three 12-month trials (945 men on finasteride, 934 on placebo): decreased libido 1.8% vs 1.3%, erectile dysfunction 1.3% vs 0.7%, decreased ejaculate volume 0.8% vs 0.4%. Overall 3.8% vs 2.1%.
- The patient leaflet lists erection problems, less desire and ejaculation problems as uncommon (up to 1 in 100). The NHS lists them as common. The BAD gives about 2%. A 2026 systematic review gives 1.9% to 6.7% against 0.9% to 3.9% on placebo.
- The SmPC says these effects resolved in men who stopped and in many who continued. Persistent dysfunction after stopping is reported after marketing, with no rate.
- The MHRA (11 May 2026) says sexual dysfunction may contribute to mood disorders, and has also been reported without mood changes.
- Tell your prescriber early. Stopping is always a valid choice.
Related guides
What counts as a sexual side effect
The Propecia (finasteride 1 mg) product information lists decreased libido, erectile dysfunction and ejaculation disorder (including decreased ejaculate volume) as uncommon effects. Testicular pain, blood in the semen and male infertility are listed with a frequency of "not known". After the tablet came on the market, persistent sexual dysfunction after stopping, covering decreased libido, erectile dysfunction and ejaculation disorder, was also reported, with no rate.
The MHRA's advice to patients is to contact your doctor about reduced sex drive, erection difficulties or ejaculation problems.
How common: the trial figures and why sources differ
UK product information. The Propecia SmPC reports three 12-month, placebo-controlled studies (945 men on finasteride 1 mg and 934 on placebo). Decreased libido was reported in 1.8% on finasteride and 1.3% on placebo, erectile dysfunction in 1.3% and 0.7%, and decreased ejaculate volume in 0.8% and 0.4%. Overall, drug-related sexual side effects in the first 12 months were 3.8% against 2.1%. The SmPC adds that these fell to 0.6% in finasteride-treated men over the following four years, with no placebo comparison for that period, and that the ejaculate volume effect in a separate study was not different from placebo.
Other sources. The patient leaflet lists the three effects as uncommon (may affect up to 1 in 100 people). The NHS lists problems getting an erection, less interest in sex and ejaculation problems as common (more than 1 in 100). The British Association of Dermatologists says decreased libido and erectile problems are recognised in approximately 2% of patients. A 2026 systematic review of 41 studies found sexual adverse events in 1.9% to 6.7% of men on oral finasteride 1 mg against 0.9% to 3.9% on placebo, and concluded that most were uncommon, mild and reversible, while stressing individual susceptibility varies.
These numbers do not agree exactly because they come from different groups of men, follow-up periods and ways of asking. Trials count what is reported in a study, and they cannot tell you your own chance. The honest summary is that most men on finasteride do not report sexual side effects, a minority do, and the MHRA is concerned enough about persistence that it has required a patient alert card and updated the warnings.
Do they go away?
The SmPC says: "Resolution of these side effects occurred in men who discontinued therapy with Propecia and in many who continued therapy". The NHS says the effects "usually improve after a while, but they can sometimes carry on even after you stop taking finasteride".
The MHRA is concerned about the group in whom they do not. In its 29 April 2024 Drug Safety Update it reported 426 Yellow Card reports of sexual dysfunction with finasteride (1 mg and 5 mg) between November 1992 and 5 April 2024, almost half recorded as "not recovered" or "not resolved". That is a count of reports, not a rate, and the MHRA says a reported reaction does not necessarily mean the medicine caused it. There is no test that predicts who will be affected. Our guide to persistent sexual side effects covers this in detail, and the post-finasteride syndrome entry explains the term.
Sexual problems and mood
The MHRA's 11 May 2026 update says the finasteride 1 mg product information is being updated to warn that sexual dysfunction may contribute to mood disorders, and that sexual dysfunction has also been reported without mood changes. So a sexual change is a reason to check in with yourself about mood as well.
If you develop depression or thoughts of suicide on finasteride 1 mg, stop it and contact your doctor as soon as possible. If you are struggling now, call Samaritans free on 116 123 at any time, call NHS 111, or call 999 or go to A&E if you feel at serious risk. See finasteride and depression.
What to do
Tell your prescriber early. You do not have to wait and see. Note what changed, when it started and how much it matters to you. They can talk through continuing with monitoring, or stopping.
Look at the whole picture. The NHS says occasional erection problems are usually caused by stress, tiredness or drinking too much alcohol, and your GP can check for other causes such as blood pressure, diabetes or hormone problems. See finasteride and alcohol.
Stopping is always valid. Our guide to stopping finasteride explains what happens to your hair and to side effects.
Report it. Report suspected side effects through the Yellow Card scheme.
Before starting finasteride, read the patient alert card, covered in what the finasteride patient alert card says, and tell the prescriber about any sexual or mood difficulties you already have.
Noticed something, or weighing it up?
If you are taking finasteride and have noticed a sexual change, a GMC-registered doctor can review it with you, including if your medicine came from another provider. If you are deciding whether to start, the doctor will go through these risks with you first.
Related questions
What percentage of men get sexual side effects on finasteride?
In the UK SmPC trials, drug-related sexual side effects were 3.8% on finasteride 1 mg against 2.1% on placebo over 12 months. Other sources give figures from about 2% to 6.7%, depending on the study and definition.
Do finasteride sexual side effects go away?
Often. The SmPC says they resolved in men who stopped and in many who continued. The MHRA warns they may persist after stopping in some, and cannot say how many.
Does finasteride lower libido?
Decreased libido is a listed side effect: 1.8% on finasteride against 1.3% on placebo in the SmPC trials. The leaflet lists it as uncommon, and the NHS as common.
Can finasteride cause erectile dysfunction?
Yes, it is a listed side effect: 1.3% on finasteride against 0.7% on placebo in the SmPC trials. Many other things cause erection problems, including stress, tiredness and alcohol, so tell your prescriber and see your GP.
Does finasteride reduce semen?
A decrease in ejaculate volume is listed in the product information (0.8% against 0.4% on placebo in trials). The NHS lists little or no semen among the effects on ejaculation.
Sources
- Propecia 1 mg: summary of product characteristics (eMC, revised 29 June 2026)
- Propecia 1 mg: patient information leaflet (eMC, revised May 2026)
- NHS: Side effects of finasteride
- British Association of Dermatologists: male pattern hair loss patient leaflet
- Złotowska A et al. Sexual dysfunction associated with 5-alpha-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review. Front Med 2026 (PMID 42396141)
- MHRA Drug Safety Update, 11 May 2026: Finasteride and dutasteride, updated safety warnings
- MHRA Drug Safety Update, 29 April 2024: Finasteride, reminder of the risk of psychiatric side effects and of sexual side effects
- NHS: Erection problems (erectile dysfunction)
Facts checked against these sources on 22 October 2026. This page is general information, not personal medical advice. Read our editorial policy.